List of biologics patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11442015 Sample test cards		bioMerieux	bioMerieux	United States Patent and Trademark Office	11442015	September 13, 2022
‌ US Patent 12070745 Isolation tube woth and endcap	Patent 12070745 was granted and assigned to bioMerieux on August, 2024 by the United States Patent and Trademark Office.	bioMerieux	bioMerieux	United States Patent and Trademark Office	12070745	August 27, 2024
‌ US Patent 8979818 Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin	Patent 8979818 was granted and assigned to Cellectis on March, 2015 by the United States Patent and Trademark Office.		Cellectis	United States Patent and Trademark Office	8979818	March 17, 2015
‌ US Patent 10260097 Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent	Patent 10260097 was granted and assigned to Almac on April, 2019 by the United States Patent and Trademark Office.		Almac	United States Patent and Trademark Office	10260097	April 16, 2019
‌ US Patent 11406981 Detection instruments with automated cell location selection for newly intaken specimen containers and related methods		bioMerieux	bioMerieux	United States Patent and Trademark Office	11406981	August 9, 2022
‌ US Patent 7183073 Method for detecting microorganisms	Patent 7183073 was granted and assigned to bioMerieux on February, 2007 by the United States Patent and Trademark Office.		bioMerieux	United States Patent and Trademark Office	7183073	February 27, 2007
‌ US Patent 10004703 Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA	Patent 10004703 was granted and assigned to Biogen on June, 2018 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	10004703	June 26, 2018
‌ US Patent 8410928 Systems and methods for evaluating chromatography column performance	Patent 8410928 was granted and assigned to Biogen on April, 2013 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8410928	April 2, 2013
‌ US Patent 11173214 Antibody-drug conjugates comprising branched linkers and methods related thereto	Patent 11173214 was granted and assigned to LegoChem Biosciences on November, 2021 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	11173214	November 16, 2021
‌ US Patent 10441556 Composition containing glibenclamide	Patent 10441556 was granted and assigned to Biogen on October, 2019 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	10441556	October 15, 2019
‌ US Patent 10478453 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10478453 was granted and assigned to Exela Pharma Sciences Llc on November, 2019 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10478453	November 19, 2019
‌ US Patent 7700097 Purification and preferential synthesis of binding molecules	Patent 7700097 was granted and assigned to Biogen on April, 2010 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7700097	April 20, 2010
‌ US Patent 10905714 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10905714 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10905714	February 2, 2021
‌ US Patent 10918662 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10918662 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10918662	February 16, 2021
‌ US Patent 8084026 Multispecific binding molecules comprising connecting peptides	Patent 8084026 was granted and assigned to Biogen on December, 2011 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8084026	December 27, 2011
‌ US Patent 8147829 Anti-IGR-1R antibodies and uses thereof	Patent 8147829 was granted and assigned to Biogen on April, 2012 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8147829	April 3, 2012
‌ US Patent 8992924 Anti-α	Patent 8992924 was granted and assigned to Biogen on March, 2015 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8992924	March 31, 2015
‌ US Patent 7943742 Anti-α	Patent 7943742 was granted and assigned to Biogen on May, 2011 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7943742	May 17, 2011
‌ US Patent 10286007 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells	Patent 10286007 was granted and assigned to Cellectis on May, 2019 by the United States Patent and Trademark Office.	Cellectis	Cellectis	United States Patent and Trademark Office	10286007	May 14, 2019
‌ US Patent 10933089 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10933089 was granted and assigned to Exela Pharma Sciences Llc on March, 2021 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10933089	March 2, 2021
‌ US Patent 10912795 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10912795 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10912795	February 9, 2021
‌ US Patent 10905713 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10905713 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10905713	February 2, 2021
‌ US Patent 11749381 Identification and antibiotic characterization of pathogens in metagenomic sample	Patent 11749381 was granted and assigned to bioMerieux on September, 2023 by the United States Patent and Trademark Office.	bioMerieux	bioMerieux	United States Patent and Trademark Office	11749381	September 5, 2023
‌ US Patent 11959060 Fluid systems, apparatuses, devices and methods of management thereof for cultivating tissue	Patent 11959060 was granted and assigned to Humacyte on April, 2024 by the United States Patent and Trademark Office.	Humacyte	Humacyte	United States Patent and Trademark Office	11959060	April 16, 2024
‌ US Patent 10583155 Stable, highly pure L-cysteine compositions for injection and methods of use	Patent 10583155 was granted and assigned to Exela Pharma Sciences Llc on March, 2020 by the United States Patent and Trademark Office.	Exela Pharma Sciences Llc	Exela Pharma Sciences Llc	United States Patent and Trademark Office	10583155	March 10, 2020

...

Results per page:

822 results

0 selected

822 results

0 selected